Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis.

Clàudia Coll-Martinez Ester QuintanaJudit Salavedra-PontMaria BuxóMarina González-Del-RioImmaculada GómezMaría Muñoz-San MartínLuisa Maria VillarGary Álvarez-BravoRené Robles-CedeñoLluís Ramió-TorrentàJordi Gich

Published in: Brain and behavior (2021)

There are no remarkable cognitive differences between LS-OCMB- and LS-OCMB+ patients in the early stages of MS.

Keyphrases

cognitive decline
multiple sclerosis
end stage renal disease
mild cognitive impairment
chronic kidney disease
newly diagnosed
ejection fraction
mass spectrometry
peritoneal dialysis
prognostic factors
ms ms
patient reported outcomes